Financial PerformancePaysign reported Q1/25 financial results that included a revenue increase of 41% to $18.6 million with a 193.3% increase in adjusted EBITDA to $4.96 million, results were better than consensus expectations.
Market PositionPaysign is a market leader in prepaid plasma donor incentive programs with 40% market share and two of the top three plasma donation center providers.
Program GrowthThe number of pharma patient affordability programs increased, contributing to a significant revenue boost.